Non-small cell lung cancer combination therapy: Hyaluronic acid modified, epidermal growth factor receptor targeted, pH sensitive lipid-polymer hybrid nanoparticles for the delivery of erlotinib plus bevacizumab

出版年份 2020 全文链接

标题

作者

关键词

Non-small cell lung cancer, Combination therapy, pH sensitive, Lipid-polymer hybrid nanoparticles, Erlotinib, Bevacizumab

出版物

BIOMEDICINE & PHARMACOTHERAPY

Volume 125, Issue -, Pages 109861

出版商

Elsevier BV

发表日期

2020-02-25

DOI

10.1016/j.biopha.2020.109861

向作者/读者发起求助以获取更多资源

Protocol

在线求助

Reagent

在线求助

Reprint

联系作者

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started